[1] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版). 临床肝胆病杂志, 2019, 35(1): 38-44.
[2] 中华医学会感染病学分会肝衰竭与人工肝学组. 非生物型人工肝治疗肝衰竭指南(2016年版). 中华临床感染病杂志, 2016, 9(02): 97-103.
[3] 秦森, 汤善宏, 王显红, 等 血清甲胎蛋白在人工肝治疗乙型肝炎相关慢加急性肝衰竭预后评估中的价值. 中华肝脏病杂志, 2020, (01): 69-70.
[4] CHEN JJ, HUANG JR, YANG Q, et al. Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China. Hepatobiliary Pancreat Dis Int, 2016, 15(3): 275-281.
[5] 郝绍瑞. 李氏人工肝系统治疗乙肝慢加急性肝衰竭的疗效和预后评价. 浙江大学, 2013.
[6] Yang Z, Zhang Z, Cheng Q, et al. Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients. Hepatol Int, 2020, 14(4): 491-502.
[7] 张爱民, 游绍莉, 万志红, et al. 血浆吸附灌流联合血浆置换加用恩替卡韦治疗乙型肝炎相关慢加急性肝衰竭的临床疗效. 临床肝胆病杂志, 2012, 28(10): 744-747.
[8] Li YH, Xu Y, Wu HM, et al. Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study. Stem Cell Rev Rep, 2016, 12(6): 645-653.
[9] 胡启江, 江应安. 拉米夫定联合血浆置换治疗乙型肝炎相关慢加急性肝衰竭的疗效分析. 临床肝胆病杂志, 2013, 29(2): 107-109.
[10] 李金强, 黎晓武, 杨丽辉, 等. 祛毒退黄汤联合血浆置换治疗乙型肝炎慢加急性肝衰竭患者的临床研究. 中国医师杂志, 2016, 18(10): 1554-1556.
[11] 毛海鹰, 滕华安, 廖礼艳, 等. 异甘草酸镁联合血浆置换治疗乙型肝炎病毒相关慢加急性肝衰竭的临床研究. 现代医学, 2019, 47(1): 38-41.
[12] Xu WX, He HL, Pan SW, et al. Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Clinical Trial in China. Stem Cells Int, 2019, 2019: 4130757.
[13] 刘春涛, 武瑞, 俞海燕, 等. 双重血浆分子吸附模式人工肝治疗乙肝相关慢加急性肝衰竭的疗效观察. 浙江医学, 2019, 41(2): 125-127,131.
[14] 李永超, 任红军, 刘磊, 等. 双重血浆吸附联合血浆置换治疗慢加急性乙型肝炎肝衰竭患者临床疗效研究. 实用肝脏病杂志, 2020, 23(2): 236-239.
[15] 董静, 刘龙梅, 陈照林, 等. 富马酸替诺福韦二吡呋酯联合双重血浆分子吸附系统序贯血浆置换治疗慢加急性乙型肝炎肝衰竭患者疗效分析. 实用肝脏病杂志, 2020, 23(5): 687-690.
[16] Wan YM, Li YH, Xu ZY, et al. Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus-infected acute-on-chronic liver failure treated by entercavir: A prospective study. J Clin Apher, 2017, 32(6): 453-461.
[17] 祝国建. 乙肝相关慢加急性肝衰竭短期预后影响因素分析及不同类型人工肝对患者预后的影响. 南昌大学, 2019.
[18] Tong JJ, Zhao W, Mu XY, et al. Predictive value of the Chinese group on the study of severe hepatitis B-acute-on-chronic liver failure score in the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Chin Med J (Engl), 2019, 132(13): 1541-1549.
[19] 杨玲玲, 李君. 乙型肝炎相关慢加急性肝衰竭诊断与预后评估的中国标准. 中华临床感染病杂志, 2019, (01): 22-23.
[20] 张文佳, 赵丽娟, 吴基洲. MELD、AARC、COSSH评分系统对乙型肝炎相关慢加急性肝衰竭90天预后的评估价值. 临床肝胆病杂志, 2020, 36(04): 813-817.
[21] Chen W, You J, Chen J, et al. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol, 2017, 23(40): 7303-7309.
[22] Yan H, Wu W, Yang Y, et al. A novel integrated Model for End-Stage Liver Disease model predicts short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure patients. Hepatol Res, 2015, 45(4): 405-414.
[23] Yang W B, Chen EQ, Bi HX, et al. Different models in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Ann Hepatol, 2012, 11(3): 311-319.
[24] 赵洁, 李力, 李秀惠, 等. 乙型肝炎病毒相关慢加急性肝衰竭患者短期预后模型的建立及预测价值研究. 中华危重病急救医学, 2020, 32(08): 988-993.
[25] 陈铿, 曹欣, 郑茵, 等. MELD-Na与CTP评分评估乙型肝炎慢加急性肝衰竭短期预后的对比研究. 中华肝脏病杂志, 2014, 22(11): 801-805.
[26] 杨涓. 终末期肝病模型(MELD)评分联合血清甲胎蛋白和胆碱酯酶对乙型肝炎病毒相关慢加急性肝衰竭患者短期预后的评估价值. 临床医学进展, 2018, 008(002): 107-114.
[27] 唐长华, 李志彬, 刘芳, 等. 不同终末期肝病模型评估血浆置换治疗慢加急性乙型肝炎肝衰竭患者短期预后. 实用肝脏病杂志, 2013, (4): 310-3.
[28] 卢萌萌. 影响乙型肝炎相关慢加急性肝衰竭患者预后的临床研究. 第四军医大学, 2017.
[29] 曹丹, 李大江, 王颖, 等. CTP联合ABIC评分预测乙型肝炎相关性慢加急性肝衰竭患者短期预后的临床意义. 中华肝脏病杂志, 2019, (02): 118-122.
[30] 宋晨源, 吴武佳, 吕元君, 等. PCT与 Child-Pugh评分对乙肝相关慢加急性肝衰竭预后的评估价值. 河南医学研究, 2014, (12): 13-16.
[31] 郑敏, 高春明, 赵久法. 血清前清蛋白联合甲胎蛋白预测乙肝相关慢加急性肝衰竭预后的价值. 安徽医学, 2019, 40(5): 514-516.
[32] 郑明华. 乙肝相关慢加急性肝衰竭预后预警模型构建. 温州医科大学, 2016.
[33] Wu J, Li YY, Hu JH, et al. Differential characteristics and prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure defined by European Association for the Study of the Liver - Chronic Liver Failure criteria. Hepatol Res, 2018, 48(2): 153-164.
[34] 包明稳, 董常峰, 冯程. 声触诊组织量化技术在评估乙肝所致慢加急性肝衰竭病情及预测预后的应用价值. 临床超声医学杂志, 2019, 21(2): 85-88.
[35] 江晓燕, 甘巧蓉, 李孝楼, 等. 血栓弹力图评价乙型肝炎病毒相关慢加急性肝衰竭患者出血风险及预后价值研究. 传染病信息, 2019, 32(01): 54-57.
[36] Xie Z, Violetta L, Chen E, et al. A prognostic model for hepatitis B acute-on-chronic liver failure patients treated using a plasma exchange-centered liver support system. J Clin Apher, 2020, 35(2): 94-103. |
